Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases. It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues. Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.

Read more in the app

Mechanism used by metastatic cancer cells to infiltrate the liver found

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

What the mechanical forces behind protein folding can tell us about metastatic cancer

A potentially more effective treatment for HER2 mutant metastatic breast cancer

Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells

The First-Ever Treatment for Non-Metastatic Brain Tumors

Unlocking the Mystery of Why a Plant Virus Is So Powerful at Fighting Cancer – Even Metastatic Cancer

HIV drug stabilizes disease progression in metastatic colorectal cancer

Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression

Metastatic prostate cancer on the rise since decrease in cancer screenings

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Personalized Immunotherapy Could Potentially Be Used To Treat Metastatic Breast Cancer

Promoter hypermethylation of SFRP1 as a blood-based prognostic biomarker in metastatic pancreatic cancer

Gene signature identifies drivers of treatment resistance in metastatic breast cancer

Metastatic prostate cancer comes in two forms, which could guide treatment